SCHEMBL2230186

SCHEMBL2230186

COCc1ccc2c(c1)ncc1ncccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.41
DYRK1A Q13627 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MAPT P10636 2/20 0.40
SYK P43405 4/20 0.39
ALOX12 P18054 2/20 0.39
HTT P42858 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GRM5 P41594 1/20 0.37
SLC22A12 Q96S37 1/20 0.36
PDE10A Q9Y233 1/20 0.36
PDGFRB P09619 1/20 0.35
PDGFRA P16234 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
CYP3A4 P08684 1/20 0.34
NR4A2 P43354 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2229954 0.80 KDM4E (0.41) KDM4EMAPTSYKCYP3A4NR4A2
SCHEMBL2229343 0.80 ADRB2 (0.44) KDM4EMAPTSYKHTTCYP3A4
SCHEMBL2231397 0.79 KDM4E (0.40) KDM4EMAPTSYKRAB9ACYP3A4
SCHEMBL3141121 0.78 CYP3A4 (0.54) HTTNPC1RAB9APDE10APDGFRB
SCHEMBL1056691 0.77 NPC1 (0.42) MAOADYRK1AKDM4EMAPTSYK
SCHEMBL13369864 0.77 KDM4E (0.42) MAOAKDM4EMAPTHTTRAB9A
SCHEMBL8602761 0.75 MAOA (0.46) MAOADYRK1ANPC1SLC22A12NOS1
SCHEMBL3136961 0.74 ALDH1A1 (0.53) KDM4EMAPTHTTNPC1RAB9A
SCHEMBL2230568 0.74 ALDH1A1 (0.56) KDM4EMAPTSYKNPC1CYP3A4
SCHEMBL31731760 0.71 MAOA (0.46) MAOADYRK1ASLC22A12CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2512478-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF Novartis AG (CH) 2012-10-24 EP disclosed
WO-2011084549-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF NOVARTIS AG (CH) 2011-07-14 WO disclosed